Drägerwerk AG & Co. KGaA EBITDA margin
Was ist das EBITDA margin von Drägerwerk AG & Co. KGaA?
EBITDA margin von Drägerwerk AG & Co. KGaA ist 1.23%
Was ist die Definition von EBITDA margin?
EBITDA margin is a profitability ratio that measures how much EBITDA the company generates as a percentage of revenue.
ttm (trailing twelve months)
EBITDA margin measures how much of EBITDA is generated as a percentage of sales. It measures the company’s operating profit as a percentage of its revenue and is calculated as EBITDA (earnings before interest, taxes, depreciation, and amortization) divided by total revenue.
EBITDA margin also helps with judging the effectiveness of cost-cutting processes at the company. The higher the company’s EBITDA margin, the lower operating expenses are in respect to revenue. As a result, a higher EBITDA margin is considered more favorable. Smaller companies can have higher EBITDA margins since they are able to operate more efficiently and maximize their profitability.
EBITDA excludes interest on debt, taxes, and capital expenditures, the margin does not provide a perfectly clear estimate of the business’s cash flow generation. Furthermore, EBITDA margin is not recognized as a GAAP (generally accepted accounting principles) metric.
EBITDA margin von Unternehmen in Health Care Sektor auf XETRA im Vergleich zu Drägerwerk AG & Co. KGaA
Was macht Drägerwerk AG & Co. KGaA?
Drägerwerk AG & Co. KGaA operates as a medical and safety technology company in Europe, the Americas, Africa, Asia, and Australia. The company develops, produces, and markets system solutions, equipment, and services for acute point of care, including emergency care, perioperative care, critical care, and perinatal care. It also develops, produces, and markets products, system solutions, and services for personal protection, gas detection technology, and integrated hazard management to customers in industry and mining sectors, as well as public sectors, such as fire departments, police, and disaster protection. The company's products portfolio includes anesthesia devices and ventilators, thermoregulation equipment, consumables and accessories, supply units, lights, gas management systems, patient monitoring, software applications, and system products. Its product portfolio also comprises stationary and mobile gas detection systems, personal protective equipment, professional diving equipment and systems, and alcohol and drug testing devices. In addition, the company offers various training and services, as well as undertakes projects that include fire training systems. Drägerwerk AG & Co. KGaA was founded in 1889 and is headquartered in Lübeck, Germany.
Unternehmen mit ebitda margin ähnlich Drägerwerk AG & Co. KGaA
- Keppel hat EBITDA margin von 1.23%
- Orient Victory Travel hat EBITDA margin von 1.23%
- Chunghwa Telecom hat EBITDA margin von 1.23%
- Hennes & Mauritz AB hat EBITDA margin von 1.23%
- Great Elm Capital Corp hat EBITDA margin von 1.23%
- CBAK Technology Inc hat EBITDA margin von 1.23%
- Drägerwerk AG & Co. KGaA hat EBITDA margin von 1.23%
- Revolution Beauty plc hat EBITDA margin von 1.24%
- Owens & Minor hat EBITDA margin von 1.24%
- Le Tanneur & Cie Societe anonyme hat EBITDA margin von 1.24%
- Central Puerto hat EBITDA margin von 1.24%
- Valson Industries hat EBITDA margin von 1.25%
- JCT hat EBITDA margin von 1.25%